These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 35001356)

  • 41. MicroRNAs in Parkinson's disease.
    Singh A; Sen D
    Exp Brain Res; 2017 Aug; 235(8):2359-2374. PubMed ID: 28526930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic networks in Parkinson's and Alzheimer's disease.
    Kelly J; Moyeed R; Carroll C; Luo S; Li X
    Aging (Albany NY); 2020 Mar; 12(6):5221-5243. PubMed ID: 32205467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between long non-coding RNAs and Alzheimer's disease: a systematic review.
    Chen L; Guo X; Li Z; He Y
    Pathol Res Pract; 2019 Jan; 215(1):12-20. PubMed ID: 30470438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
    Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
    Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studying the system-level involvement of microRNAs in Parkinson's disease.
    Chatterjee P; Bhattacharyya M; Bandyopadhyay S; Roy D
    PLoS One; 2014; 9(4):e93751. PubMed ID: 24690883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.
    Qureshi YH; Baez P; Reitz C
    Mol Cell Biol; 2020 Sep; 40(19):. PubMed ID: 32690545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.
    Martinez-Finley EJ; Avila DS; Chakraborty S; Aschner M
    Metallomics; 2011 Mar; 3(3):271-9. PubMed ID: 21210060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of obesity on neurodegenerative diseases.
    Mazon JN; de Mello AH; Ferreira GK; Rezin GT
    Life Sci; 2017 Aug; 182():22-28. PubMed ID: 28583368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y; Liu H; Zhang L; Lv W; Hu X
    Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parkinson's disease and Alzheimer's disease: a Mendelian randomization study.
    Han Z; Tian R; Ren P; Zhou W; Wang P; Luo M; Jin S; Jiang Q
    BMC Med Genet; 2018 Dec; 19(Suppl 1):215. PubMed ID: 30598082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissecting the limited genetic overlap of Parkinson's and Alzheimer's disease.
    Stolp Andersen M; Tan M; Holtman IR; Hardy J; ; Pihlstrøm L
    Ann Clin Transl Neurol; 2022 Aug; 9(8):1289-1295. PubMed ID: 35684951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases.
    Maruszak A; Gaweda-Walerych K; Sołtyszewski I; Zekanowski C
    Acta Neurobiol Exp (Wars); 2006; 66(2):153-76. PubMed ID: 16886726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary Study of hsa-mir-626 Change in the Cerebrospinal Fluid in Parkinson's Disease.
    Qin LX; Tan JQ; Zhang HN; Tang JG; Jiang B; Shen XM; Guo JF; Tan LM; Tang B; Wang CY
    Neurol India; 2021; 69(1):115-118. PubMed ID: 33642281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
    Wang J; Chen C; Zhang Y
    J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of the Inflammasome in Neurodegenerative Diseases.
    Piancone F; La Rosa F; Marventano I; Saresella M; Clerici M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
    Huang P; Zhang LY; Tan YY; Chen SD
    Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.